Drugs / CD34+ and CD133+ stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02687672 | Jan 2016 → Jun 2021 | spinal cord injury | Stem Cells Arabia | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ and CD133+ stem cells | “purified, autologous CD34+ and CD133+ stem cells (SCs)” NCT02687672 ↗ |
| Modality | Cell therapy | “purified, autologous CD34+ and CD133+ stem cells (SCs)” NCT02687672 ↗ |